UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
                       Pursuant to Section 13 OR 15(d) of
                       The Securities Exchange Act of 1934

        Date of Report (Date of earliest event reported) January 4, 2006


                               SWISS MEDICA, INC.
             (Exact name of registrant as specified in its charter)


          Delaware                     000-09489                 98-0355519
(State or other jurisdiction          (Commission              (IRS Employer
      of incorporation)               File Number)           Identification No.)


                    53 Yonge Street, 3rd Floor            M5E 1J3
                    Toronto, Ontario, Canada
            (Address of principal executive offices)     (Zip Code)

        Registrant's telephone number, including area code (416) 868-0202


--------------------------------------------------------------------------------
         (Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR
    230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
    240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
    Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
    Act (17 CFR 240.13e-4(c))

<PAGE>

This Form 8-K and other reports filed by Swiss Medica, Inc. (the "Registrant" or
the "Company") from time to time with the Securities and Exchange Commission
(collectively the "Filings") contain forward looking statements and information
that are based upon beliefs of, and information currently available to, the
Registrant's management as well as estimates and assumptions made by the
Registrant's management. When used in the Filings the words "anticipate",
"believe", "estimate", "expect", "future", "intend", "plan" or the negative if
these terms and similar expressions as they relate to the Registrant or the
Registrant's management identify forward looking statements. Such statements
reflect the current view of the Registrant with respect to future events and are
subject to risks, uncertainties, assumptions and other factors relating to the
Registrant's industry, operations and results of operations and any businesses
that may be acquired by the Registrant. Should one or more of these risks or
uncertainties materialize, or should the underlying assumptions prove incorrect,
actual results may differ significantly from those anticipated, believed,
estimated, expected, intended or planned.

Item 1.01   Entry into a Material Definitive Agreement.

Pursuant to a Commitment Letter dated as of December 23, 2005, as amended, by
and between the Registrant and Reid Partners 1 Inc. ("Lender"), the Registrant
borrowed on a non-revolving basis, $400,000 CAD ($346,000 USD). The Registrant
paid a loan processing fee of $9,000 CAD ($7,800 USD) to Lender in connection
with the Note. An additional loan fee of $25,000 CAD ($22,000 USD) is owed to
Lender on March 28, 2006.

To evidence this arrangement, the Registrant executed a promissory note ("Note")
in the principal amount of $425,000 CAD ($368,000 USD) to Lender on January 4,
2006. There is no interest on the Note, unless the Note is not paid by March 28,
2006 at which time interest will accrue at 24% per annum. The Note maybe prepaid
at any time, without penalty. The Note is guaranteed by the Registrant's Chief
Executive Officer, Raghunath Kilambi and a shareholder of the Registrant. Both
Mr. Kilambi and the other shareholder have each personally pledged certain
assets as a security interest for the loan. The Note is due and payable on March
28, 2006.

Item 2.03   Creation of a Direct Financial Obligation or an Obligation under an
Off-Balance Sheet Arrangement of a Registrant.

      (a)   Disclosure of direct financial obligation.

            (1)   On January 4, 2006, the Registrant became obligated to pay
                  Lender amounts due under a promissory note in the principal
                  amount of $425,000 CAD ($368,000 USD). The details of this
                  Note are described in Item 1.01 listed above.

            (2)   The Note is due and payable on March 28, 2006 ("Maturity
                  Date").

            (3)   If the loan is not repaid by the Maturity Date, interest
                  accrues at 24% per annum, on a monthly basis.

            (4)   The Note is guaranteed by the Registrant's Chief Executive
                  Officer, Raghunath Kilambi and another shareholder of the
                  Registrant who have each pledged certain assets as a security
                  interest for the loan.

            (5)   The Note may be prepaid at any time, without interest or
                  penalty.

      (b)   Off-Balance Sheet Arrangement: None

Item 3.02   Unregistered Sale of Equity Securities.

The Company issued the Note described under Item 1.01 to the Lender on January
4, 2006. The issuance of these securities was exempt from registration under
Section 4(2) of the Securities Act of 1933.


Item 9.     Financial Statements and Exhibits

<PAGE>

      (a)   Financial Statements of Businesses Acquired.

            Not applicable.

      (b)   Pro Forma Financial Information

            Not applicable

      (c)   Shell Company Transactions

            Not applicable

      (d)   Exhibits.


      Exh. No.          Description
      --------          -----------

      10.1.             Commitment Letter by and between Registrant and Reid
                        Partners 1 Inc. dated December 23, 2005, as amended by
                        that amendment dated December 28, 2005

      10.2.             Form of Promissory Note

      10.3.             Share Pledge Agreement dated January 4, 2006 by and
                        between Reid Partners 1 Inc. and Raghunath Kilambi.



                                   SIGNATURES

      Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.


                                                 SWISS MEDICA, INC.
                                                    (Registrant)


Date: January 24, 2006             By: /s/ Bruce Fairbairn
                                       ----------------------------------------
                                       Bruce Fairbairn, Chief Financial Officer
{"company-data": {"conformed-name": "SWISS MEDICA INC", "cik": "0000318245", "assigned-sic": "2834", "irs-number": "980355519", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-09489", "film-number": "06559467"}, "business-address": {"street1": "53 YONGE STREET, 3RD FLOOR", "street2": "TORONTO", "city": "ONTARIO, CANADA", "state": "A1", "zip": "M5E 1J3", "phone": "416-657-4134"}, "mail-address": {"street1": "53 YONGE STREET, 3RD FLOOR", "street2": "TORONTO", "city": "ONTARIO, CANADA", "state": "A1", "zip": "M5E 1J3"}, "former-company": [{"former-conformed-name": "SWISS MEDIA INC", "date-changed": "20030702"}, {"former-conformed-name": "GLOBAL PATH INC", "date-changed": "20010814"}, {"former-conformed-name": "YOURNET INC/", "date-changed": "19991108"}]}
UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
                       Pursuant to Section 13 OR 15(d) of
                       The Securities Exchange Act of 1934

        Date of Report (Date of earliest event reported) January 4, 2006

                               SWISS MEDICA, INC.
             (Exact name of registrant as specified in its charter)

          Delaware                     000-09489                 98-0355519
(State or other jurisdiction          (Commission              (IRS Employer
      of incorporation)               File Number)           Identification No.)

                    53 Yonge Street, 3rd Floor            M5E 1J3
                    Toronto, Ontario, Canada
            (Address of principal executive offices)     (Zip Code)

        Registrant's telephone number, including area code (416) 868-0202

--------------------------------------------------------------------------------
         (Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR
    230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
    240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
    Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
    Act (17 CFR 240.13e-4(c))
This Form 8-K and other reports filed by Swiss Medica, Inc. (the "Registrant" or
the "Company") from time to time with the Securities and Exchange Commission
(collectively the "Filings") contain forward looking statements and information
that are based upon beliefs of, and information currently available to, the
Registrant's management as well as estimates and assumptions made by the
Registrant's management. When used in the Filings the words "anticipate",
"believe", "estimate", "expect", "future", "intend", "plan" or the negative if
these terms and similar expressions as they relate to the Registrant or the
Registrant's management identify forward looking statements. Such statements
reflect the current view of the Registrant with respect to future events and are
subject to risks, uncertainties, assumptions and other factors relating to the
Registrant's industry, operations and results of operations and any businesses
that may be acquired by the Registrant. Should one or more of these risks or
uncertainties materialize, or should the underlying assumptions prove incorrect,
actual results may differ significantly from those anticipated, believed,
estimated, expected, intended or planned.

Item 1.01   Entry into a Material Definitive Agreement.

Pursuant to a Commitment Letter dated as of December 23, 2005, as amended, by
and between the Registrant and Reid Partners 1 Inc. ("Lender"), the Registrant
borrowed on a non-revolving basis, $400,000 CAD ($346,000 USD). The Registrant
paid a loan processing fee of $9,000 CAD ($7,800 USD) to Lender in connection
with the Note. An additional loan fee of $25,000 CAD ($22,000 USD) is owed to
Lender on March 28, 2006.

To evidence this arrangement, the Registrant executed a promissory note ("Note")
in the principal amount of $425,000 CAD ($368,000 USD) to Lender on January 4,
2006. There is no interest on the Note, unless the Note is not paid by March 28,
2006 at which time interest will accrue at 24% per annum. The Note maybe prepaid
at any time, without penalty. The Note is guaranteed by the Registrant's Chief
Executive Officer, Raghunath Kilambi and a shareholder of the Registrant. Both
Mr. Kilambi and the other shareholder have each personally pledged certain
assets as a security interest for the loan. The Note is due and payable on March
28, 2006.

Item 2.03   Creation of a Direct Financial Obligation or an Obligation under an
Off-Balance Sheet Arrangement of a Registrant.

      (a)   Disclosure of direct financial obligation.

            (1)   On January 4, 2006, the Registrant became obligated to pay
                  Lender amounts due under a promissory note in the principal
                  amount of $425,000 CAD ($368,000 USD). The details of this
                  Note are described in Item 1.01 listed above.

            (2)   The Note is due and payable on March 28, 2006 ("Maturity
                  Date").

            (3)   If the loan is not repaid by the Maturity Date, interest
                  accrues at 24% per annum, on a monthly basis.

            (4)   The Note is guaranteed by the Registrant's Chief Executive
                  Officer, Raghunath Kilambi and another shareholder of the
                  Registrant who have each pledged certain assets as a security
                  interest for the loan.

            (5)   The Note may be prepaid at any time, without interest or
                  penalty.

      (b)   Off-Balance Sheet Arrangement: None

Item 3.02   Unregistered Sale of Equity Securities.

The Company issued the Note described under Item 1.01 to the Lender on January
4, 2006. The issuance of these securities was exempt from registration under
Section 4(2) of the Securities Act of 1933.

Item 9.     Financial Statements and Exhibits
(a)   Financial Statements of Businesses Acquired.

            Not applicable.

      (b)   Pro Forma Financial Information

            Not applicable

      (c)   Shell Company Transactions

            Not applicable

      (d)   Exhibits.

      Exh. No.          Description
      --------          -----------

      10.1.             Commitment Letter by and between Registrant and Reid
                        Partners 1 Inc. dated December 23, 2005, as amended by
                        that amendment dated December 28, 2005

      10.2.             Form of Promissory Note

      10.3.             Share Pledge Agreement dated January 4, 2006 by and
                        between Reid Partners 1 Inc. and Raghunath Kilambi.

                                   SIGNATURES

      Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                                 SWISS MEDICA, INC.
                                                    (Registrant)

Date: January 24, 2006             By: /s/ Bruce Fairbairn
                                       ----------------------------------------
                                       Bruce Fairbairn, Chief Financial Officer